Pharmaceutical, Drugs, Medicine, Biology, FDA.
patient registries, may lead to improved target identification and validation. Lack of biomarkers: Biomarkers are objective measures that can be used to detect and measure biological states, and they are critical for assessing the efficacy of new drugs. However, there is currently a lack of